Page last updated: 2024-09-05

dabigatran and Cardiovascular Diseases

dabigatran has been researched along with Cardiovascular Diseases in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's35 (94.59)24.3611
2020's2 (5.41)2.80

Authors

AuthorsStudies
Barrios, V; Escobar, C1
Bernardini, F; Marchetti, G; Romoli, M; Urbinati, S1
Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y1
Eek, AK; Granas, AG; Øie, E1
Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T1
Gottsäter, A1
Amin, A; Baker, CL; Carda, E; Dhamane, A; Dina, O; Keshishian, A; Mardekian, J; Nadkarni, A; Rosenblatt, L; Russ, C; Yuce, H1
Agewall, S; Andreotti, F; Atar, D; Cattaneo, M; Collet, JP; Grove, EL; Huber, K; Husted, S; Kjeldsen, K; Lip, GY; Morais, J; Pathak, A; Rosano, G; Storey, RF; Verheugt, FW; Wassmann, S1
Stiefelhagen, P1
Attia, JR; Pearce, R1
Bazargan, A; Douglas, G; McKenzie, JL1
Hughes, DA; Pink, J; Pirmohamed, M1
Cameron, C; Coyle, D; Coyle, K; Kelly, S; Lee, K; Steiner, S; Wells, GA1
Bertoletti, L; Da Costa, A; Durupt, S; Epinat, M; Laporte, S; Lega, JC; Mismetti, P1
Finsterer, J; Krutisch, G; Stöllberger, C1
Barillari, G; Cheng, JW1
Douketis, J; Ing, E1
Bruyère, O; Buckinx, F; Dogné, JM; Douxfils, J; Hainaut, P; Minet, V; Mullier, F; Rabenda, V; Reginster, JY1
Amirehsani, KA; Scott, KA1
Aleil, B; Krieger, C; Stephan, D1
Lane, DA; Lee, SI; Lip, GY; Sayers, M1
Drambarean, B; Hellenbart, E; Lee, J; Nutescu, EA1
Eikelboom, J; Weitz, JI1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH; Yen, KC1
Al-Khalili, F; Benson, L; Lindström, C1
Johansson, PI; Ostrowski, SR; Solbeck, S; Stensballe, J1
Hussain, SS; Mukherjee, D; Tyroch, AH1
Dellegrottaglie, S; Filippatos, G; Giugliano, RP; Lund, LH; Magnani, G; McMurray, J; Perrone-Filardi, P; Rosano, GM; Savarese, G; Trimarco, B1
Azuma, J; Maegdefessel, L; Spin, JM; Tsao, PS1
Ahrens, I; Lip, GY; Peter, K1
Panchenko, EP1
Connolly, SJ; Ezekowitz, MD; Reilly, PA; Wallentin, L; Yusuf, S1
Pendleton, RC; Rodgers, GM; Smock, KJ; Wilcox, R1
Connolly, SJ; Eikelboom, JW; Lamy, A; Margetts, P; Ricci, C; Warkentin, TE1
Rami, BK1
Livio, F1

Reviews

14 review(s) available for dabigatran and Cardiovascular Diseases

ArticleYear
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
    Clinical therapeutics, 2017, Volume: 39, Issue:7

    Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin

2017
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
    European heart journal, 2013, Volume: 34, Issue:23

    Topics: Adenosine; Aspirin; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Warfarin

2013
Perioperative management of anticoagulation in elective surgery.
    ANZ journal of surgery, 2013, Volume: 83, Issue:11

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Diseases; Clopidogrel; Dabigatran; Elective Surgical Procedures; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Thromboembolism; Ticlopidine; Withholding Treatment

2013
Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2013, Volume: 16, Issue:4

    Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Cost-Benefit Analysis; Dabigatran; Drug Costs; Hemorrhage; Humans; Markov Chains; Middle Aged; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Time Factors; Warfarin

2013
Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Journal of clinical pharmacy and therapeutics, 2014, Volume: 39, Issue:2

    Topics: Administration, Oral; Animals; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes

2014
New oral anticoagulants and oculoplastic surgery.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2014, Volume: 49, Issue:2

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Cataract Extraction; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Surgery, Plastic; Thiophenes

2014
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.
    Journal of the American Heart Association, 2014, Jun-06, Volume: 3, Issue:3

    Topics: Benzimidazoles; Cardiovascular Diseases; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Mortality; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Venous Thromboembolism

2014
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation.
    Thrombosis and haemostasis, 2016, Volume: 115, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Stroke; Thiazoles; Warfarin

2016
Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
    Cardiovascular & hematological agents in medicinal chemistry, 2017, Volume: 14, Issue:2

    Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Arginine; Blood Coagulation; Blood Coagulation Factors; Cardiovascular Diseases; Dabigatran; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Models, Molecular; Piperazines; Recombinant Proteins

2017
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
    JACC. Heart failure, 2016, Volume: 4, Issue:11

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiovascular Diseases; Cause of Death; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Failure; Hemorrhage; Humans; Intracranial Hemorrhages; Mortality; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin

2016
New options with dabigatran etexilate in anticoagulant therapy.
    Vascular health and risk management, 2010, May-25, Volume: 6

    Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Blood Coagulation; Cardiovascular Diseases; Dabigatran; Drug Administration Schedule; Drug Interactions; Fibrinolytic Agents; Hemorrhage; Humans; Pyridines; Thrombin; Treatment Outcome

2010
New oral anticoagulant drugs in cardiovascular disease.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:1

    Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Cardiovascular Diseases; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Prothrombin; Pyridines; Rivaroxaban; Thiophenes; Vitamin K

2010
Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.
    Hospital practice (1995), 2011, Volume: 39, Issue:3

    Topics: Antithrombins; Benzimidazoles; Blood Coagulation Tests; Cardiovascular Diseases; Clinical Trials as Topic; Dabigatran; Dose-Response Relationship, Drug; Enoxaparin; Humans; Pyridines; Venous Thromboembolism; Warfarin

2011
[Pharmacovigilance update].
    Revue medicale suisse, 2013, Jan-09, Volume: 9, Issue:368

    Topics: Adrenergic Uptake Inhibitors; Age Factors; Aged; Amides; Antihypertensive Agents; Atomoxetine Hydrochloride; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Fibrinolytic Agents; Fumarates; Hemorrhage; Humans; Pharmacovigilance; Propylamines

2013

Other Studies

23 other study(ies) available for dabigatran and Cardiovascular Diseases

ArticleYear
Atrial fibrillation, an equivalent of cardiovascular disease risk.
    European heart journal, 2020, 12-21, Volume: 41, Issue:48

    Topics: Anticoagulants; Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Dabigatran; Humans; Thrombin; Warfarin

2020
Switching across direct oral anticoagulants: a real-life-setting pilot prospective study.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2021, 06-01, Volume: 22, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Dabigatran; Drug Monitoring; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Factor Xa Inhibitors; Female; Heart Disease Risk Factors; Humans; Italy; Long Term Adverse Effects; Male; Medication Therapy Management; Risk Adjustment; Rivaroxaban

2021
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    European journal of clinical pharmacology, 2018, Volume: 74, Issue:3

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Cardiovascular Diseases; Clinical Decision-Making; Dabigatran; Drug Monitoring; Drug Resistance; Factor Xa Inhibitors; Focus Groups; General Practitioners; Hemorrhage; Humans; Medical Staff, Hospital; Medication Adherence; Norway; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Qualitative Research; Risk; Rivaroxaban; Warfarin

2018
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events.
    Critical pathways in cardiology, 2018, Volume: 17, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin

2018
[NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease].
    Lakartidningen, 2018, 12-04, Volume: 115

    Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Cardiovascular Diseases; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Myocardial Infarction; Myocardial Ischemia; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Sweden; Thiazoles

2018
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.
    Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiovascular Diseases; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Medicare; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; United States; Warfarin

2019
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)].
    MMW Fortschritte der Medizin, 2013, Feb-21, Volume: 155, Issue:3

    Topics: Adenosine; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Fibrinolytic Agents; Guideline Adherence; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine; Treatment Outcome

2013
The use, misuse and abuse of dabigatran.
    The Medical journal of Australia, 2013, Apr-15, Volume: 198, Issue:7

    Topics: Advertising; Anticoagulants; Antithrombins; Aspirin; Australia; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Insufficiency; Research Design; Selection Bias; Stroke; Warfarin

2013
Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation.
    Clinical pharmacology and therapeutics, 2013, Volume: 94, Issue:2

    Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Comorbidity; Computer Simulation; Dabigatran; Female; Hemorrhage; Humans; Male; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Time Factors; Warfarin

2013
[New oral anticoagulants in nonvalvular atrial fibrillation].
    Presse medicale (Paris, France : 1983), 2013, Volume: 42, Issue:9 Pt 1

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Humans; Pyrazoles; Pyridones; Stroke

2013
Life-threatening epistaxis and red blood cell polyagglutination under dabigatran.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:4

    Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Epistaxis; Female; Humans

2014
Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation.
    Journal of the American Association of Nurse Practitioners, 2015, Volume: 27, Issue:4

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiovascular Diseases; Dabigatran; Hemorrhage; Humans; Stroke; Warfarin

2015
[Prospective study of the new oral anticoagulants in private practice: cautious optimism].
    Annales de cardiologie et d'angeiologie, 2015, Volume: 64, Issue:2

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Cardiology; Cardiovascular Diseases; Dabigatran; Factor Xa Inhibitors; Female; France; General Practice; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Surveys and Questionnaires; Thromboembolism; Treatment Outcome

2015
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    International journal of clinical practice, 2015, Volume: 69, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Audit; Dabigatran; Drug Substitution; Female; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Warfarin

2015
The evolving role of dabigatran etexilate in clinical practice.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:13

    Topics: Antithrombins; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials as Topic; Dabigatran; Enoxaparin; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism

2015
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    Stroke, 2016, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Taiwan; Warfarin

2016
The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic.
    Current medical research and opinion, 2016, Volume: 32, Issue:4

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Vitamin K

2016
Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
    International journal of cardiology, 2016, Apr-01, Volume: 208

    Topics: Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Dabigatran; Drug Monitoring; Female; Humans; Male; Middle Aged; Reference Standards; Thrombelastography

2016
[Anticoagulant therapy in cardiology: yesterday, today, tomorrow].
    Kardiologiia, 2010, Volume: 50, Issue:7

    Topics: Anticoagulants; Benzimidazoles; Carboxypeptidase B2; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dabigatran; Fibrinolytic Agents; Humans; Morpholines; Pyridines; Receptor, PAR-1; Rivaroxaban; Thiophenes; Thrombin; Thrombomodulin; Thrombosis; Treatment Outcome; Warfarin

2010
Newly identified events in the RE-LY trial.
    The New England journal of medicine, 2010, Nov-04, Volume: 363, Issue:19

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Cardiovascular Diseases; Dabigatran; Embolism; Hemorrhage; Humans; Myocardial Infarction; Pyridines

2010
I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
    DukeMedicine healthnews, 2012, Volume: 18, Issue:1

    Topics: Anticoagulants; Benzimidazoles; Cardiovascular Diseases; Dabigatran; Drug Approval; Drug Interactions; Food-Drug Interactions; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2012
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
    Blood, 2012, Mar-01, Volume: 119, Issue:9

    Topics: Aged; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Factor VIIa; Humans; Male; Postoperative Hemorrhage; Recombinant Proteins; Renal Dialysis; Treatment Outcome

2012
Direct thrombin inhibitors' potential efficacy in Alzheimer's disease.
    American journal of Alzheimer's disease and other dementias, 2012, Volume: 27, Issue:8

    Topics: Aged; Alzheimer Disease; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Endothelium, Vascular; Heparin; Humans; Thrombin

2012